Related Experiment Video
Updated: Mar 28, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Adaptation of Cost Analysis Studies in Practice Guidelines
Fainareti N Zervou1, Ioannis M Zacharioudakis, Elina Eleftheria Pliakos
1From the Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903.
Clinical guidelines rarely incorporate cost analyses, using only 6% of available studies. Improving reporting standards and linking costs to outcomes could enhance resource allocation in healthcare.
Area of Science:
- Health Economics
- Clinical Practice Guidelines
- Health Services Research
Background:
- Clinical guidelines are essential for daily medical practice.
- Incorporating cost analyses into guidelines can optimize resource allocation.
- The extent to which cost analyses are integrated into clinical guidelines is not well understood.
Purpose of the Study:
- To assess the incorporation of cost analyses into clinical guidelines.
- To identify factors influencing the level of cost analysis integration.
- To evaluate the quality of incorporated cost analyses.
Main Methods:
- Analysis of 100 highly cited clinical guidelines from the National Guideline Clearinghouse.
- Quantification of cost analysis incorporation and comparison across medical specialties.
- Case-control study matching incorporated and non-incorporated cost analyses based on Consolidated Health Economic Evaluation Reporting Standards (CHEERS) criteria.
Main Results:
- 57% of guidelines lacked cost justification.
- Guidelines incorporated only 6% of available cost analyses, with significant variation by specialty.
- Incorporated analyses showed better adherence to CHEERS requirements, stronger links between cost reduction and outcomes, and more frequent funding source disclosure.
Conclusions:
- Clinical guidelines underutilize cost analyses for efficient resource allocation.
- Enhancing adherence to reporting standards like CHEERS and transparently reporting funding sources may increase guideline developers' use of cost analyses.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Dosage Regimens: Designs and Approaches
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen: Individualization

